Abstract
Cholesteatoma is a destructive lesion of the temporal bone that gradually expands and causes complications by erosion of the adjacent bony structures. Bone resorption can result in destruction of the ossicular chain and otic capsule with consecutive hearing loss, vestibular dysfunction, facial paralysis and intracranial complications. Surgery is the only treatment of choice. The etiopathogenesis of cholesteatoma, however, is still controversial. This review was designed to understand the reasons for these disparities and to reduce or eliminate them. Future studies focused on developmental, epidemiological, hormonal and genetic factors as well as on treatment are likely to contribute to further understanding of cholesteatoma pathogenesis.
Similar content being viewed by others
References
Abramson M (1964) Collagenolytic activity in middle ear cholesteatoma. Ann Otol Rhinol Laryngol 78: 112–124
Abramson M, Huang CC (1977) Localization of collagenase in human middle ear cholesteatoma. Laryngoscope 87: 771–791
Ahn JM, Huang CC, Abramson M (1990) Interleukin-1 causing bone destruction in middle ear cholesteatoma. Otolaryngol Head Neck Surg 103: 527–536
Aimi K (1983) Role of the tympanic ring in the pathogenesis of congenital cholesteatoma. Laryn-goscope 93: 1140–1146
Akimoto R, Pawankar R, Yagi T, Baba S (2000) Acquired and congenital choleteatoma: determination of tumor nectosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process. ORL 62: 257–265
Albino AP, Reed JA, Bogdany JK, Sassoon J, Desloge RB, Parisier SC (1998) Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications. Am J Otol 19: 30–36
Albino AP, Reed JA, Bogdany JK, Sassoon J, Parisier SC (1998) Increased numbers of mast cells in human middle ear. cholesteatomas: implications for treatment. Am J Otol 9: 266–272
Albino PA, Kimmelmann CP, Parisier SC (1998) Cholesteatoma: a molecular and cellular puzzle. Am J Otol 19: 7–19
Amling M, Delling G (1996) Zellbiologie des Osteoklasten und molekulare Mechanismen der Knochenresorption. Pathologe 17: 358–367
Arriaga MA, Dixon P (1998) Cytotoxicity of cytokeratin monoclonal antibody against kera-tinocytes: a possible therapeutic adjunct for cholesteatoma? Am J Otol 19: 26–29
Austin DF (1969) Types and indications of staging. Arch Otolaryngol 89: 235–242
Baki FA, El Dine MB, El Saiid I, Bakry M (2002) Sinus tympani endoscopic anatomy. Otolaryngol Head Neck Surg 127: 158–162
Banerjee AR, James R, Narula AA (1998) Matrix metalloproteinase-2 and matrix metalloproteinase-9 in cholesteatoma and deep meatal skin. Clin Otolaryngol 23: 345–347
Banerjee AR, James R, Narula AA, Lee RJ (1998) Matrixmetalloproteinase-1 in cholesteatoma, middle ear granulations and deep meatal skin: a comparative analysis. Clin Otolaryngol 23: 515–519
Bezold F (1890) Cholesteatom, Perforation der Membrana flaccida und Tubenverschluß. Z Hals Nasen Ohrenheilk 20: 5–29
Bravo R, Frank R, Blundell P, McDonald-Bravo H (1987) Cyclin/PCNA is the auxillary protein of DANN polymerase-delta. Nature 326: 515–517
Bujia J, Holly A, Schilling V, Negri B, Pitzke P, Schulz P (1993) Aberrant expression of epidermal growth factor receptor in aural cholesteatoma. Laryngoscope 103: 326–329
Bujia J, Holly A, Kim C, Sudhoff H, Ostos P, Kastenbauer E (1996) Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: An analysis of protein production and gene expression. Am J Otol 17: 1–4
Bujia J, Schilling V, Holly A, Stammberger M, Kastenbauer E (1993) Hyperproliferation-associated keratin expression in human middle ear cholesteatoma. Acta Otolaryngol (Stockh) 113: 364–368
Bujía J, Holly A, Sudhoff H, Antolí- Candela F, Tapia MG, Kastenbauer E (1996) Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67. ORL Otorhinolaryngol Relat Spec 58: 23–26
Bujia J, Kim C, Ostos P, Sudhoff H, Kastenbauer E, Hültner I (1996) Interleukin-1 (Il-1) and Il-1-R antagonist (Il-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity. Eur Arch Otorhinolaryngol 253: 252–255
Bujia J, Sudhoff H, Holly A, Hildmann H, Kastenbauer E (1996) Immunohistochemical detection of proliferation cell nuclear antigen in middle ear cholesteatoma. Eur Arch Otorhinolaryngol 253: 21–24
Chambers TJ, Darby JA, Fuller K (1985) Mammalian collagenase predisposes bone surfaces to osteoclastic resorption. Cell Tissue Res 241: 671–675
Chole RA (1993) Bone resorption in aural cholesteatoma. In: Fourth International Conference on Cholesteatoma and Mastoid Surgery. Kugler, Amsterdam, pp 79–83
Chole RA, Frush D (1982) Quantitative studies of eustachian tube epithelium during experimental vitamin A deprivation and reversal. Kugler, Amsterdam
Chole RA, Tinling SP (1985) Basal lamina breaks in the histogenesis of cholesteatoma. Laryngoscope 95: 270–275
Chole RA, Henry KR, McGinn MD (1981) Cholesteatoma: spontaneous occurence in the Mongolian gerbil Meriones unguiculatus. Am J Otol 2: 204–210
Choufani G, Mahillon V, Decaestecker C, Lequeux T, Danguy A, Salmon I, Gabius H-J, Hassid S, Kiss R (1999) Determination of the levels of expression of sarcolectin and calcyclin and of the percentages of apoptotic but not proliferating cells to enable distinction between recurrent and nonrecurrent cholesteatomas. Laryngoscope 109: 1825–1831
Chung JW, Yoon TH (1998) Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium. Acta Otolaryngol (Stockh) 118: 386–391
Cinamon U, Kronenberg J, Benayahu D (2000) Structural changes and protein expression in the mastoid bone adjacent to cholesteatoma. Laryngoscope 110: 1198–1203
The Committee of Conservation of Hearing of the American Academy of Ophthalmology and Otolaryngology (1965) Standard classification for surgery of chronic ear disease. Arch Otolaryngol 81: 204–205
Cruveilhier J (1829) Anatomie pathologique du corps humain. Bailliere, Paris
Dallari S, Cavani A, Bergamini G, Girolomoni G (1994) Integrin expression in middle ear cholesteatoma. Acta Otolaryngol (Stockh) 114: 188–192
Darrouzet V, Duclos J-Y, Portmann D, Bebear J-P (2002) Congenital middle ear cholesteatomas in children: our experience in 34 cases. Otolaryngol Head Neck Surg 126: 34–41
Derlacki EL, Clemis JD (1965) Congenital cholesteatoma of the middle ear and mastoid. Ann Otol Rhinol Laryngol 74: 706–727
Desloge RB, Carew JF, Finstad CL, Steiner MG, Sassoon J, Levenson MJ, Staiano-Coico L, Parisier SC, Albino AP (1997) DNA analysis of human cholesteatomas. Am J Otol 18: 155–159
DuVerney JG (1683) Traite de l'organe de l'ouie, contenant Structure. Les ufages et leas maladies des toutes les parties de l'orelle. E. Michallet, Paris
Elias PM, Wood LC, Feingold KR (1999) Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermat 10: 119–126
Ergun S, Carsloo B, Zheng X (1999) Apoptosis in meatal skin, cholesteatoma and squamous cell carcinoma of the ear. Clin Otolaryngol 24: 280–285
Felix R, Fleisch H, Elford PR (1989) Bone-resorbing cytokines enhance release of macrophage colony stimulating activity by the osteoblastic cell MC3T3-E1. Calcif Tissue Int 44: 356–360
Fransson J, Hammar H (1992) Epidermal growth in skin equivalent. Arch Dermatol Res 284: 343–348
Friedmann I (1955) The comparative pathology of otitis media—experimental and human. II. The histopathology of experimental otitis of the guinea pig, with particular reference to experimental cholesteatoma. J Laryngol Otol 69: 588–601
Friedmann I (1971) Epidermoid cholesteatoma and cholesterol granuloma. Ann Otol Rhinol Laryngol 68: 57–80
Fujioka C, Huang CC (1994) Platelet-derived growth factor in middle ear cholesteatoma. Eur Arch Otorhinolaryngol 251: 199–204
Grundfast KM, Ahuja GS, Parisier SC, Culver SM (1995) Delayed diagnosis and fate of congenital cholesteatoma (keratoma). Arch Otolaryngol Head Neck Surg 121: 903–907
Habermann J (1888) Zur Entstehung des Cholesteatoms des Mittelohres. Arch Ohrenheilkd 27: 43–51
Hayashida T, Iwamori M, Kitsuwa T, Nagai Y, Nomura Y (1984) Biochemical study of cholesteatoma and cholesterol granuloma occurrence of delta 7 cholesterol in the tissue of cholesteatoma. ORL J Otorhinolaryngol Relat Spec 46: 242–247
Holly A, Sittinger M, Bujia J (1995) Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma. Eur Arch Otorhinolaryngol 252: 366–369
Huang CC, Yi ZX, Chao WY (1988) Effects of granulation tissue conditioned medium on the in-vitro differentiation of keratinocytes. Arch Otorhinolaryngol 245: 325–329
Huang T, Yan SD, Huang CC (1989) Colony-stimulating factor in middle ear cholesteatoma. Am J Otolaryngol 10: 393–398
Ishibashi T, Shinogami M, Kaga K, Fukaya T (1997) Keratinocyte growth factor and receptor mRNA expression in cholesteatoma of the middle ear. Acta Otolaryngol (Stockh) 117: 714–718
Jung JY, Chole RA (2002) Bone resorption in chronic otitis media: the role of the osteoclast. ORL 64: 95–107
Kakoi H, Tamagawa Y, Kitamura K, Anniko M, Hiraide F, Kitajima Y (1995) Cytokeratin expression patterns by one- and two-dimensional electrophoresis in pars flaccida cholesteatoma and pars tensa cholesteatoma. Acta Otolaryngol (Stockh) 115: 804–810
Karmody CS, Bybhatti SV, Vltonen H, Northrop C (1998) The origin of congenital cholesteatoma. Am J Otol 19: 292–297
Kato A, Ohashi Y, Masamoto T, Sakamoto H, Uekawa M, Nakai Y (1998) Interleukin-6 and tumour necrosis factor alpha synthesized by cholesteatoma cells affect mucociliary function in the eustachian tube. Acta Otolaryngol [Suppl] 538: 90–97
Kayhan FT, Mutlu C, Schachern PA, Le CT, Paparella MM (1997) Significance of epidermoid formations in the middle ear in fetuses and children. Arch Otolaryngol Head Neck Surg 123: 1293–1297
Kemppainen HO, Puhakka HJ, Laippala PJ, Sipila MM, Manninen MP, Karma PH (1999) Epidemiology and aetiology of middle ear cholesteatoma. Acta Otolaryngol 119: 568–572
Kim CS, Chung JW (1999) Morphologic and biologic changes of experimentally induced cholesteatoma in Mongolian gerbils with anticytokeratin and lectin study. Am J Otol 20: 13–18
Kim H-J, Tinling SP, Chole RA (2001) Expression patterns of cytokeratins in retraction pocket cholesteatomas. Laryngoscope 111: 1032–1036
Kim H-J, Tinling SP, Chole RA (2002) Expression patterns of cytokeratins in cholesteatomas: evidence of increased migration and proliferation. J Korean Med Sci 17: 381–388
Kojima H, Tanaka Y, Tanaka T, Miyazaki H, Shiwa M, Kamide Y, Moriyama H (1998) Cell proliferation and apoptosis in human middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg 124: 261–264
Kojima H, Miyazaki H, Shiwa M, Tanaka Y, Moriyama H (2001) Molecular biological diagnosis of congenital and aquired cholesteatoma on the basis of differences in telomere length. Laryngoscope 111: 867–873
Koltai PJ, Nelson M, Castellon RJ, Garabedian E-N, Triglia J-M, Roman S, Roger G (2002) The natural history of congenital cholesteatoma. Arch Otolaryngol Head Neck Surg 128: 804–809
Kountakis SE, Chang CYJ, Gormley WB, Cabral FR (2000) Migration of indtradural epidermoid matrix: embryologic implications. Otolaryngol Head Neck Surg 123: 170–173
Kuijpers W, Vennix PP, Peters TA, Ramaekers FC (1996) Squamous metaplasia of the middle ear epithelium. Acta Otolaryngol (Stockh) 116: 293–298
Lang S, Schilling V, Wollenberg B, Mack B, Nerlich A (1997) Localization of transforming growth factor-beta-expressing cells and comparison with major extracellular components in aural cholesteatoma. Ann Otol Rhinol Laryngol 106: 669–673
Lange W (1925) Über die Entstehung der Mittelohrcholesteatoma. Z Hals Nas Ohrenheilk 11: 250–271
Lee TS, Liang JN, Michaels L, Wright A (1998) The epidermoid formation and its affinity to congenital cholesteatoma. Clin Otolaryngol 23: 449–454
Levenson MJ, Parisier SC, Chute P, S. W, Juarbe CA (1986) A review of 20 congenital cholesteatomas of the middle ear in children. Otolaryngol Head Neck Surg 94: 560–567
Levine JL, Wright CG, Pawlowski KS, Meyerhoff WL (1998) Postnatal persistence of epidermoid rests in the human middle ear. Laryngoscope 108: 70–73
Lim D, Birck H, Saunders W (1977) Aural cholesteatoma and epidermization: a fine morphological study. In: McCabe BF, Sade J, Abramson M (eds) Cholesteatoma. First Intenational Conference. Aesculapius, Briminham, pp 233–252
Lucae A (1873) Beiträge zur Kenntnis der Perlgeschwülste des Felsenbeins. Arch Ohr Nas Kehlk Hk 7: 255
Masaki M, Wright CG, Lee DH, Meyerhoff ML (1989) Epidermal ingrowth through tympanic membrane following middle ear application of propylene glycol. Acta Otolaryngol (Stockh) 108: 169–174
Mc Cawley LJ, O'Brien P, Hudson LG (1998) Epidermal growth factor (EGF)- and scatter factor factor/hepatocyte growth factor (SF/HGF)-madiated keratinocyte migration is coincident with induction of matrix-metalloproteinase (MMP)-9. J Cell Physiol 176: 255–265
McGill TJ, S. Merchant, G. B. Healy, Friedman EM (1991) Congenital cholesteatoma of the middle ear in children: a clinical and histopathological report. Laryngoscope 101: 606–613
McKennan KX, Chole RA (1989) Post-traumatic cholesteatoma. Laryngoscope 99: 779–782
Meyerhoff WL, Truelson J (1986) Cholesteatoma staging. Laryngoscope 96: 935–939
Michaels L (1986) An epidermoid formation in the developing middle ear; possible source of cholesteatoma. J Otolarnygol 15: 169–174
Michaels L (1987) Cholesteatoma. Ear, Nose Throat Histopathology. Springer, New York Heidelberg Berlin
Michaels L (1988) Origin of congenital cholesteatoma from a normally occurring epidermoid rest in the developing middle ear. Int J Pediatric Otolaryngol 15: 51–65
Milewski C, Fedorowski A, Stan AC, Walter GF (1998) Basic fibroblast growth factor (b-FGF) in the perimatrix of cholesteatoma. HNO 46: 804–808
Mills RP, Padgham ND (1991) Management of childhood cholesteatoma. J Laryngol Otol 105: 343–345
Miyazaki H, Kojima H, Tanaka Y, Shiwa M, Koga T, Moriyama H (1999) Terminal differentiation of epithelial cells in middle ear choleseatoma: investigation of patterns of expression of protein kinase C-? and protein kinase C-? Laryngoscope 109: 1785–1792
Mizutani H, Ohyanagi S, Hayashi T, Groves RW, Suzuki K, Shimizu M (1996) Functional thrombomodulin expression on epithelial skin tumors as a differentiation marker for suprabasal keratinocytes. Br J Dermatol 135: 187–193
Müller J (1838) Über den feineren Bau und die Formen der krankhaften Geschwülste. Reimer, Berlin
Myers EN, Park K, Chun Y, Lee D, Hwang S (1999) Signal transduction pathway in human middle ear cholesteatoma. Otolaryngol Head Neck Surg 120: 899–904
Negri B, Schilling V, Bujia J, Schulz P, Kastenbauer E (1992) Immunotype findings in macrophages in aural cholesteatomas. Eur Arch Otorhinolaryngol 249: 87–90
Nelson M, Roger G, Koltai PJ, Garabedian E-N, Triglia J-M., Roman S, Castellon RJ, Hammel JP (2002) Congenital cholesteatoma: classification, management, and outcome. Arch Otolaryngol Head Neck Surg 128: 810–814
Nemes Z, Steinert PM (1999) Bricks and mortar of the epidermal barrier. Exp Mol Med 31: 5–19
Northrop C, Piza J, Eavey RD (1986) Histological observations of amniotic fluid cellular content in the ear of neonates and infants. Int J Pediatr Otorhinolaryngol 11: 113–127
Olszewska E, Chodynicki S, Chyczewski L (2003) Some markers of proliferative activity in cholesteatoma epithelium in adults. Otolaryngol Pol 57: 85–89
Orisek BS, Chole RA (1987) Pressures exerted by experimental cholesteatomas. Arch Otolaryngol Head Neck Surg 113: 386–391
Ottaviani F, Sambataro G, Mantovani M, Lavezzi AM, Matturi L (1989) Middle ear cholesteatoma. A cytodiagnostic study of cellular proliferative activity. Kugler and Ghedini, Amsterdam
Ottaviani F, Neglia CB, Berti E (1999) Cytokines and adhesion molecules in middle ear cholestetoma. A role in epithelial growth? Acta Otolaryngol 119: 462–467
Palva T, Taskinen E (1990) Inflammatory cells in chronic middle ear disease. Acta Otolaryngol (Stockh) 109: 124–129
Paparella MM, Rybak L (1978) Congenital cholesteatoma. Otolaryngol Clin North Am 11: 113–120
Parisier SC, Levenson MJ, Edelstein DR, Bindra GS, Han JC, Dolitsky JN (1989) Management of congenital pediatric cholesteatomas. Am J Otol 10: 121–123
Park HJ, Park K (1999) Expression of Fas/APO-1 and apoptosis of keratinocytes in human cholesteatoma. Laryngoscope 109: 613–616
Park K, Chun Y-M, Park H-J, Lee Y-D (1999) Immunohistochemical study of cell proliferation using BrdU labeling on tympanic membrane, external auditory canal and induced cholesteatoma in Mongolian gerbils. Acta Otolaryngol (Stockh) 119: 874–879
Park K, Park H-J, Chun Y-M (2001) Immunohistochemical study on proliferative activity of expwrimental cholesteatoma. Eur Arch Otorhinolaryngol 258: 101–105
Paukkonen K, Naukkarinen A, Horsmanheimo M (1995) The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes. Arch Dermatol Res 287: 165–170
Polakowska RP, Placentini M, Bartlett R, Goldsmith LA, Haake AR (1994) Apoptosis in human skin development: morphogenesis periderm and stemcells. Dev Dynamics 199: 176–188
Potsic WP, Wetmore RF, March RR (1997) Congenital cholesteatoma: 15 years experience at the childrens hospital of Philadelphia. In: Fifth International Conference on Cholesteatoma and Mastoid Surgery. CIC Edizioni Internationali, Rome, pp 422–431
Potsic WP, Korman SB, Samadi DS, Wetmore RF (2002) Congenital cholesteatoma: 20-year experience at the Children's Hospital of Philadelphia. Otolaryngol Head Neck Surg 126: 409–414
Quantin L, Fernández SC, Moretti J (2002) Congenital cholesteatoma of external auditory canal. Int J Pediatr Otorhinolaryngol 62: 175–179
Rashad U, Hawthorne M, Kumar U, Welsh A (1999) Unusual cases of congenital cholesteatoma of the ear. J Laryngol Otol 131: 52–54
Ratnesar P (1977) Aeration: a factor in the sequele of chronic ear disease along the Labrador and northern Newfoundland Coast. In: McCabe B, Sade J, Abramson M (eds) Cholesteatoma: First international conference. Aesculapius, Birmingham, pp 302–307
Remak R (1854) Ein Beitrag zur Entwicklungsgeschichte der Geschwulste. Deutsche Klin 6: 170
Richardson AC, Tinling SP, Chole RA (1993) Risedronate activity in the fetal and neonatal mouse. Otolaryngol Head Neck Surg 109: 623–633
Roach HI (1994) Why does bone matrix contain non collagenous proteins? The possible roles of osteocalcin, osteonectin, osteopontin, and bone sialoprotein in bone mineralisation and resorption. Cell Biol Int 18: 617–628
Robey PG, Boskey AL (1996) The biochemistry of bone: review. Stanford University School of Medicine, Stanford, California
Robinson AC, Hawke M (1991) The motility of keratinocytes in cholesteatoma: an ultrastructural approach to epithelial migration. J Otolaryngol 20: 353–359
Ruedi L (1978) Pathogenesis and surgical treatment of the middle ear cholesteatoma. Acta Otolaryngol (Stockh) [Suppl] 361: 1–45
Sadé J (1979) The atelectatic ear. Churchill Livingstone, New York
Sadé J (1971) Cellular differentiation in the middle ear lining. Ann Otol Rhinol Laryngol 80: 376
Sadé J, Berco E, Buyanover D, Brown M (1981) Ossicular damage in chronic middle-ear inflammation. Acta Otolaryngol 92: 273–283
Sadé J (2000) The buffering effect of middle ear negative pressure by retraction of the pars tensa. Am J Otol 21: 20–23
Saleh HA, Mills RP (1999) Classification and staging of cholesteatoma. Clin Otolaryngol 24: 355–359
Sanna M, Mazzoni A, Landolfi M, Aristegni M (1994) Treatment of petrous bone cholesteatoma. Acta Otorrinolaringol Esp 45: 143–152
Schilling V, Negri B, Bujia J, Schulz P, Kastenbauer E (1992) Possible role of interleukin 1a and interleukin 1b in the pathogenesis of cholesteatoma of middle ear. Am J Otol 13: 350–355
Schimdt M, Grünsfelder, Hoppe F (2000) Induction of matrix metalloproteinases in keratinocytes by cholesteatoma debris and granulation issue extracts. Eur Arch Otorhinolaryngol 257: 425–429
Schimdt M, Grünsfelder, Hoppe F (2001) Up-regulation of matrix metalloprotease-9 in middle ear cholesteatoma: correlations with growth factor expression in vivo? Eur Arch Otorhinolaryngol 258: 472–476
Schönermark M, Mester B, Kempf HG, Blaser J, Tschesche H, Lenarz T (1996) Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. Acta Otolaryngol 116: 451–456
Schuknecht HF (1993) Pathology of the ear, Series 2. Lea and Feabinger, Philadelphia
Sheikholeslam- Zadeh R, Decaestecker C, Delbrouck C, Danguy A, Salmon I, Zick Y, Kaltner H, Hassid S, Gabius H-J, Kiss R, Choufani G (2001) The levels of expression of galectin- 3, but not of galectin- 1 and galectin- 8, correlate with apoptosis in human cholesteatomas. Laryngoscope 111: 1042–1047
Shinoda H, Huang CC (1995) Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death. Laryngoscope 105: 1232–1237
Soyer HP, Smolle J, Smolle- Juettner FM, Kerl H (1989) Proliferation antigens in cutaneous melanocytic tumors: an immunohistochemical study comparing the transferrin receptor and the Ki-67 antigen. Dermatologica 173: 3–9
Srinivasan V, Banhegyi G, O'Sullivan G, Shermann IW (2000) Pars tensa retraction pockets in children: treatment by excision and ventilation tube insertion. Clin Otolaryngol 25: 253–256.
Stark T, Sudhoff H, Fisseler-Eckhoff A, Borkowski G, Luckhaupt H, Hildmann H (1997) Alterations of basement membrane in middle ear cholesteatoma. In: Sanna M (ed) Fifth international conference on cholesteatoma and mastoid surgery. CIC Edizioni Internationali, Rome, pp 238–247
Steinbach E (1982) Experimental studies on cholesteatoma formation. Kugler, Amsterdam
Steinbach E, Hildmann, H. (1972) Re-use of incus in cholesteatoma and in chronic mucosal disease. Z Laryngol Rhinol 51: 659–664
Sudhoff H, Tos M (2000) Pathogenesis of attic cholesteatoma: clinical and immunohistochemical support for combination of retration theory and proliferation theory. Am J Otol 21: 786–792
Sudhoff H, Linthicum FHJ (2001) Cholesteatoma behind an intact tympanic membrane: histopathologic evidence for a tympanic membrane origin. Otol Neurotol 22: 444–446
Sudhoff H, Hildmann H (2003) Gegenwärtige Theorien zur Cholesteatomentstehung. HNO 51: 71–83
Sudhoff H, Bujia J, Holly A, Kim C, Fisseler-Eckhoff A (1994) Functional characterization of middle ear mucosa residues in cholesteatoma samples. Am J Otol 15: 217–221
Sudhoff H, Bujia J, Fisseler-Eckhoff A, Schulz-Flake C, Holly A, Hildmann H (1995) Expression of the cell-cycle-related antigen (MIB 1) in cholesteatoma and auditory meatal skin. Laryngoscope 105: 1227–1231
Sudhoff H, Bujia J, Fisseler-Eckhoff A, Borkowski G, Holly A, Koc C, Hildmann H (1996) Basement membrane in middle ear cholesteatoma. Immunohistochemical and ultrastructural observations. Ann Otol Rhinol Laryngol 105: 804–810
Sudhoff H, Fisseler-Eckhoff A, Borkowski G, Luckhaupt H, Stark T, Hildmann H (1997) Cholesteatoma and angiogenesis. In: Sanna Me (ed) Fifth international conference on cholesteatoma and mastoid surgery. CIC Edizioni Internationali, Rome, pp 264–272
Sudhoff H, Fisseler-Eckhoff A, Stark T, Borkowski G, Luckhaupt H, Cooper J, Michaels L (1997) Agyrophilic nuclear organizer regions in auditory skin and cholesteatoma. Clin Otolaryngol 6: 545–548
Sudhoff H, Dazert S, Gonzales AM, Borkowski G, Park SY, Baird A, Hildmann H, Ryan AF (2000) Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Am J Otol 21: 793–798
Svane-Knudsen V, Halkier-Sorensen L, Rasmussen G, Ottosen PD (2001) Cholesteatoma: a morphologic study of stratum corneum lipids. Acta Otolaryngol 121: 602–606
Tanaka Y, Kojima H, Miyazaki H, Koga T, Moriyama H (1999) Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium. Laryngoscope 109: 1102–1107
Teed RW (1936) Cholesteatoma verum tympani: its relationship to the first epibranchial placode. Arch Otolaryngol 24: 455–474
Tos M (1988) Incidence, etiology and pathogenesis of cholesteatoma in children. Otol Rhinol Laryngol 40: 110–117
Tos M (1993) Manual of middle ear surgery. Thieme, Stuttgart, New York
Tos M (2000) A new pathogenesis of mesotympanic (congenital) cholesteatoma. Laryngoscope 110: 1890–1897
Tos M, Lau T (1989) Recurrence and the condition of the cavity after surgery for cholesteatoma using various techniques. Kugler and Ghedini, Amsterdam
Tos M, Stangerup S-E, Larsen P, Siim C, Andreassen U (1989) The relationship between secretory otitis and cholesteatoma. In: Tos M, Thomsan J, Peiteresen E (eds) Proceedings of the 3rd international conference on cholesteatoma and mastoid surgery. Kugler Ghedini, Amsterdam pp 325–330
von Tröltsch A (1864) The diseases of the ear, their diagnosis and treatment. William Wood, New York
Van Den Oord JJ, De Ley M, De Wolf-Peeters C (1993) Distribution of gamma interferon receptors in normal and active psoriatic skin. In: Schlossman SF BL, Gilks W, et al (eds) Fifth international workshop and conference. Oxford University Press, Boston, pp 1994–1995
Vennix PP, Kuijpers W, Peters TA, Tonnaer EL, Ramaekers FC (1996) Keratinocyte differentiation in acquired cholesteatoma and perforated tympanic membranes. Arch Otolaryngol Head Neck Surg 122: 825–832
Virchow R (1855) Über Perlgeschwülste (Cholesteatoma Joh. Müller). p 371
Wang RG, Hawke M, Kwok P (1987) The epidermoid formation (Michaels structure) in the developing middle ear. J Otolaryngol 16: 327–330
Wendt H (1873) Desquamative Entzündung des Mittelohres ("Cholesteatom des Felsenbeins"). Arch Ohr Nasen Kehlkopfheilk 14: 428–446
Wittmaack K (1933) Wie entsteht ein genuines Cholesteatom? Arch Otorhinolaryngol 137: 306
Wright CG, Meyerhoff WL, Burns DK (1985) Middle ear cholesteatoma: an animal model. Am J Otolaryngol 6: 327–341
Wright CG, Bird LL, Meyerhoff WL (1991) Tympanic membrane microstructure in experimental cholesteatoma. Acta Otolaryngol (Stockh) 111: 101–111
Wright CG, Robinson KS, Meyerhoff WL (1996) External and middle ear pathology in TGF-alpha-deficient animals. Am J Otol 17: 360–365
Wullstein H (1956) Theory and practice of tympanoplasty. Laryngoscope 66: 1076–1093
Wullstein HL, Wullstein SR (1980) Cholesteatoma. Etiology, nosology and tympanoplasty. ORL J Otorhinolaryngol Relat Spec 42: 313–335
Yan SD, Huang CC (1991) Lymphotoxin in human middle ear cholesteatoma. Laryngoscope 101: 411–415
Yan SD, Huang CC (1991) The role of tumor necrosis factor-alpha in bone resoption in cholesteatoma. Am J Otol 12: 82–89
Young MF, Kerr JM, Ibaraki K, Heegaard AM, Robey PG (1992) Structure, expression, and regulation of the major noncollagenous matrix proteins of bone. Clin Orthop Relat Res 281: 275–294
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Olszewska, E., Wagner, M., Bernal-Sprekelsen, M. et al. Etiopathogenesis of cholesteatoma. Eur Arch Otorhinolaryngol 261, 6–24 (2004). https://doi.org/10.1007/s00405-003-0623-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-003-0623-x